Investors | Eli Lilly and CompanyFDA Approves Lilly and Incyte's OLUMIANT® (baricitinib) As First and Only Systemic Medicine for Adults with Severe ...Jun 13, 2022more_vert
NBC NewsFirst alopecia treatment for autoimmune disorder that causes sudden hair loss approved by the FDAJun 14, 2022Berkeley Lovelace & Berkeley Lovelace Jr.By Berkeley Lovelace & Berkeley Lovelace Jr.more_vert
The New York TimesF.D.A. Approves Alopecia Drug That Restores Hair Growth in Many Patients (Published 2022)Jun 13, 2022Gina KolataBy Gina Kolatamore_vert